Hatch/Waxman Reform Hearings Urged By Governors Association
This article was originally published in The Tan Sheet
Eight governors and an employer coalition are urging Congress to "close the loopholes" that allow brand name companies to use the 30-month Hatch/Waxman stay of approval provisions to delay generic launches
You may also be interested in...
The revised McCain/Schumer generic drug bill eliminates the automatic stay of approval under current patent challenge procedures.
Perrigo promotes in pricing, planning
Combe sells most of its OTC brands